Literature DB >> 2153178

IL-1 activates two separate signal transduction pathways in T helper type II cells.

E Muñoz1, U Beutner, A Zubiaga, B T Huber.   

Abstract

We have investigated the signal transduction pathways mediated by IL-1 in the Th 2 cell line D10.A, and we have made the following findings. Interaction of IL-1 with its receptor leads to the translocation of protein kinase C (PKC) from the cytosol to the membrane, phosphorylation of the 80-kDa protein that is substrate for PKC, as well as an increase in the level of cAMP. In addition, IL-1 induced IL-5 mRNA expression in these cells. We have established that the IL-5 gene is activated in D10.A cells in response to either phorbol esters or 8-Br cAMP, and that the two agents act as cofactors. IL-1 is able to synergize with phorbol esters and is additive with 8-Br cAMP for IL-5 mRNA expression. There are two possibilities to explain these results: 1) D10.A cells express two types of functional IL-1R, each linked to an independent signal transduction pathway; or 2) these cells have only one kind of IL-1R which, upon ligand interaction, mediates the activation of both the PKC and the adenylate cyclase pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153178

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Evidence that responses of articular chondrocytes to interleukin-1 and basic fibroblast growth factor are not mediated by protein kinase C.

Authors:  K I Hulkower; H I Georgescu; C H Evans
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells.

Authors:  E Muñoz; A M Zubiaga; J Muñoz; B T Huber
Journal:  Cell Regul       Date:  1990-04

3.  Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts.

Authors:  D Hormdee; T Nagasawa; M Kiji; R Yashiro; H Kobayashi; G Koshy; K Noguchi; H Nitta; I Ishikawa
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  The polymeric immunoglobulin receptor (secretory component) in a human intestinal epithelial cell line is up-regulated by interleukin-1.

Authors:  M Hayashi; N Takenouchi; M Asano; M Kato; T Tsurumachi; T Saito; I Moro
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

5.  Interleukin 1-beta-induced protein kinase C-zeta activation is mimicked by exogenous phospholipase D.

Authors:  C Limatola; B Barabino; A Nista; A Santoni
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

6.  Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes.

Authors:  G C Newbound; J M Andrews; J P O'Rourke; J N Brady; M D Lairmore
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression.

Authors:  K Ye; K C Koch; B D Clark; C A Dinarello
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

8.  Requirements for the induction of the interleukin-2 receptor complex in a human pre-T-cell line.

Authors:  P D Salvati; S E Peroni; P R Ranford; U R Kees
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

9.  A comparison of the effects of signal transduction inhibitors on oxidative burst and degranulation in IL-I beta stimulated bovine neutrophils.

Authors:  P W Yu; C J Czuprynski
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

10.  Investigation of guanine-nucleotide-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction.

Authors:  K Ray; N Thompson; N Kennard; P Rollins; S Grenfell; S Witham; N Smithers; R Solari
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.